You are currently viewing a new version of our website. To view the old version click .

Nuclear Medicine and Radiotherapy in Cancer Treatment

This special issue belongs to the section “Applied Biosciences and Bioengineering“.

Special Issue Information

Dear Colleagues,

In tackling the global health challenge of cancer, this Special Issue offers a critical exploration of innovative solutions. As technology assumes an increasingly pivotal role in modern medicine, the convergence of nuclear and radiation physics with oncology presents boundless potential. Radiation therapy, a cornerstone in cancer treatment, provides precise and effective means to combat tumors and alleviate patient suffering. On the other hand, nuclear medicine's versatile applications, spanning from precise imaging for diagnosis, planning, and follow-up, to targeted therapies using radiopharmaceuticals, have revolutionized cancer care, ushering in personalized treatment paradigms.

This Special Issue serves as a platform to delve into recent advancements and pioneering techniques in both domains. We welcome original contributions that probe into the development of cutting-edge methodologies for accurate diagnosis, treatment planning, and/or follow-up, alongside optimized approaches for radiation therapy-related dosimetry and technical enhancements in therapy delivery.

Let us collectively propel the frontiers of nuclear medicine and radiotherapy, striving towards heightened efficacy, diminished toxicity, and enhanced outcomes in cancer treatment.

Dr. Pedro Costa
Guest Editor

Dr. Ana Cravo Sá
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer treatment
  • dosimetry
  • nuclear medicine
  • PET
  • radioisotope therapy
  • radiotherapy
  • treatment planning

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Appl. Sci. - ISSN 2076-3417